According to Ramsay Health Care's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.7137. At the end of 2021 the company had a P/E ratio of 30.3.
Year | P/E ratio | Change |
---|---|---|
2021 | 30.3 | -39.86% |
2020 | 50.3 | 82.62% |
2019 | 27.5 | 1.18% |
2018 | 27.2 | -6.14% |
2017 | 29.0 | -2.83% |
2016 | 29.9 | 0.59% |
2015 | 29.7 | 26.06% |
2014 | 23.5 | 10.95% |
2013 | 21.2 | 55.43% |
2012 | 13.7 | 17.49% |
2011 | 11.6 | -31.38% |
2010 | 16.9 | -10.42% |
2009 | 18.9 | 26.72% |
2008 | 14.9 | -13.66% |
2007 | 17.3 | -16.78% |
2006 | 20.8 | -48.63% |
2005 | 40.4 | 126.81% |
2004 | 17.8 | 36.96% |
2003 | 13.0 | -27.09% |
2002 | 17.8 | -17.22% |
2001 | 21.6 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.